| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |